共 92 条
[1]
Aldape K(2015)Glioblastoma: pathology, molecular mechanisms and markers Acta Neuropathol 129 829-848
[2]
Zadeh G(2014)Malignant brainstem gliomas in adults: clinicopathological characteristics and prognostic factors J Neuro-Oncol 119 177-185
[3]
Mansouri S(2013)Clinical characteristics and treatment of malignant brainstem gliomas in elderly patients J Clin Neurosci 20 1382-1386
[4]
Reifenberger G(2012)MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status Acta Neuropathol 124 547-560
[5]
von Deimling A(2009)Identification of regions correlating MGMT promoter methylation and gene expression in glioblastomas Neuro-Oncology 11 348-356
[6]
Babu R(2005)MGMT gene silencing and benefit from temozolomide in glioblastoma N Engl J Med 352 997-1003
[7]
Kranz PG(2015)Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers Acta Neuropathol 129 669-678
[8]
Agarwal V(2017)Genomic insights into diffuse intrinsic Pontine Glioma Front Oncol 7 57-537 e525
[9]
McLendon RE(2017)Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic Pontine Glioma Cancer Cell 32 520-8844
[10]
Thomas S(2003)Silencing effect of CpG island hypermethylation and histone modifications on O6-methylguanine-DNA methyltransferase (MGMT) gene expression in human cancer Oncogene 22 8835-411